Cite
HARVARD Citation
Bachert, C. et al. (2022). Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. International forum of allergy & rhinology. 12 (9), pp. 1191-1195. [Online].